News
Novo Nordisk (NVO) and Hims & Hers (HIMS) are in focus after the pair's weight loss drug partnership fell apart. Investors are eyeing Micron's (MU) third quarter results after the closing bell. Stay ...
Novo Nordisk (NVO) and Hims & Hers (HIMS) are in focus after the pair's weight loss drug partnership fell apart. Investors are eyeing Micron's (MU) third quarter results after the closing bell. Stay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback